UK Ibrance Patient Program (IPP) Study
Condition: HR+/HER2- Locally Advanced, Metastatic Breast Cancer Intervention: Drug: Palbociclib Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials